Clinical Trials Browser

Astrocytoma × Aminolevulinic Acid × Clear all

NCT06665724 2026-02-27

Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Phase 1 Completed

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT01148966 2017-02-15

Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors

Phase 1 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT02119338 2017-01-06

5-ALA in Recurrent Glioma

Phase NA Unknown

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT01502605 2017-01-05

Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas

Phase 1 Terminated

Astrocytoma, Brain Neoplasms, Glioma

NCT01351519 2016-03-17

A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors

Phase 2 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma